Firefly Neuroscience, Inc.
AIFF
$3.02
-$0.01-0.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -241.61% | 11.75% | -239.32% | -12.66% | -4.18% |
| Total Depreciation and Amortization | 375.00% | 0.00% | 0.00% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 872.20% | -54.42% | 4,253.45% | -1.69% | -13.24% |
| Change in Net Operating Assets | -158.22% | 278.79% | -836.89% | 140.23% | -151.30% |
| Cash from Operations | -106.16% | 51.65% | -129.21% | 16.68% | -158.63% |
| Capital Expenditure | 91.25% | -1,900.00% | 93.75% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 104.71% | 27.35% | 10.69% | 66.06% |
| Cash from Investing | 90.79% | 14.61% | 50.83% | -38.17% | 66.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 921.76% | -75.17% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 447.12% | -46.15% | -- | -100.00% | -55.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,233.62% | -33.49% | 168.13% | -153.47% | -140.40% |